A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis
Clinical trial NCT03922607 · COMPLETED
Trial details
- NCT number
- NCT03922607
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-11
- Primary completion
- 2021-04-13
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.